NCT05105685View on ClinicalTrials.gov

Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 14, 2020

Primary Completion Date

May 12, 2021

Study Completion Date

June 8, 2021

Conditions
Phelan-McDermid SyndromeGrowth Hormone Treatment
Interventions
DRUG

recombinant human growth hormone

RhGH treatment was started at 0.1 IU/kg once daily

DRUG

Saline

Saline was started at 0.1 IU/kg once daily as the placebo

Trial Locations (1)

226600

Affiliated Hospital of JiangNan University, Department of Pediatrics, Wuxi

All Listed Sponsors
lead

Affiliated Hospital of Jiangnan University

OTHER

NCT05105685 - Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS | Biotech Hunter | Biotech Hunter